Literature DB >> 14531556

Postoperative imaging after brain tumor resection.

M Warmuth-Metz1.   

Abstract

Prognosis after surgery for a brain tumor is not only influenced by its histology but also by the completeness of resection. The exact identification of a possible residual tumor is crucial also for follow-up and the purpose of evaluation of response to treatment. A review of the current and past literature addressing the individual value, the technique, and the pitfalls of postoperative imaging with Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) for the definition of a postoperative residue after the resection of brain tumors is given. The different problems and possibilities are illustrated by imaging examples.

Entities:  

Mesh:

Year:  2003        PMID: 14531556     DOI: 10.1007/978-3-7091-6090-9_4

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  6 in total

1.  Contrast-enhanced MR imaging of brain lesions: a large-scale intraindividual crossover comparison of gadobenate dimeglumine versus gadodiamide.

Authors:  H A Rowley; G Scialfa; P-y Gao; J A Maldjian; D Hassell; M J Kuhn; F J Wippold; M Gallucci; B C Bowen; I M Schmalfuss; J Ruscalleda; S Bastianello; C Colosimo
Journal:  AJNR Am J Neuroradiol       Date:  2008-07-03       Impact factor: 3.825

2.  [Germ cell and embryonal tumors].

Authors:  W Reith; R Mühl-Benninghaus; A Simgen; U Yilmaz
Journal:  Radiologe       Date:  2014-08       Impact factor: 0.635

Review 3.  Neuroradiologic review in pediatric brain tumor studies.

Authors:  Monika Warmuth-Metz; Brigitte Bison; Susanne Leykamm
Journal:  Klin Neuroradiol       Date:  2009-11-21

Review 4.  Improving lesion detection and visualization: implications for neurosurgical planning and follow-up.

Authors:  Piero Picozzi; Miles A Kirchin
Journal:  Neuroradiology       Date:  2007-07       Impact factor: 2.804

5.  Multicenter, double-blind, randomized, intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine in MRI of brain tumors at 3 tesla.

Authors:  Zoran Rumboldt; Howard A Rowley; Fred Steinberg; Joseph A Maldjian; Jordi Ruscalleda; Lars Gustafsson; Stefano Bastianello
Journal:  J Magn Reson Imaging       Date:  2009-04       Impact factor: 4.813

Review 6.  Use of contrast agents in oncological imaging: magnetic resonance imaging.

Authors:  Giovanni Morana; Christian Cugini; Giuliano Scatto; Riccardo Zanato; Michele Fusaro; Alberto Dorigo
Journal:  Cancer Imaging       Date:  2013-09-23       Impact factor: 3.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.